NFKB1 and cancer: QRT has been shown to downregulate the NF-κB pathway, thereby inhibiting the expression of anti-apoptotic and pro-inflammatory genes in cancer cells and this inhibition occurs primarily through the suppression of IκB kinase (IKK), which prevents the phosphorylation and degradation of IκB, the inhibitor of NF-κB [129].